Tel Aviv Stock Exchange

ZOOZ Power Ltd. Ordinary Shares and Public Warrants to Trade on Nasdaq on April 5, 2024, as the Business Combination between Keyarch Acquisition Corporation and ZOOZ Power Ltd. Has Been Completed

Retrieved on:

Thursday, April 4, 2024

EV, Growth, Cayman Islands, Tel Aviv Stock Exchange, EVS, Security (finance), Business analyst, PIPE, KYCH

NEW YORK, NY, April 04, 2024 (GLOBE NEWSWIRE) -- Keyarch Acquisition Corporation (Nasdaq: KYCH), a Cayman Islands exempted company (“Keyarch”), and ZOOZ Power Ltd. (TASE: ZOOZ), a limited liability company organized under the laws of the State of Israel (“ZOOZ” or the “Company”) and a leading provider of flywheel-based power boosting solutions for the EV charging infrastructure market, today jointly announced the consummation of their previously disclosed business combination (the “Business Combination”). The Business Combination and related proposals were approved by Keyarch shareholders in its shareholders’ meeting held on March 27, 2024 and by ZOOZ shareholders in its shareholders’ meetings held on March 21, 2024 and March 27, 2024.

Key Points:

The Business Combination and related proposals were approved by Keyarch shareholders in its shareholders’ meeting held on March 27, 2024 and by ZOOZ shareholders in its shareholders’ meetings held on March 21, 2024 and March 27, 2024.
Following the consummation of the Business Combination, ZOOZ becomes dual-listed for trading on the Nasdaq and on the Tel-Aviv Stock Exchange.
ZOOZ’s ordinary shares and public warrants will begin trading on Nasdaq under the ticker symbols “ZOOZ” and “ZOOZW,” respectively, on April 5, 2024.
Additional information regarding the closing of the Business Combination will be included in a current report on Form 8-K to be filed by Keyarch with the Securities and Exchange Commission.

Formula Systems Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on:

Tuesday, March 19, 2024

Hamas, Tax, Tel Aviv Stock Exchange, Iron, TSG, Matrix, Formula, American depositary receipt, Investment, Formula Systems

Financial Highlights for the Fourth Quarter Ended December 31, 2023

Key Points:

Financial Highlights for the Fourth Quarter Ended December 31, 2023
Consolidated revenues for the fourth quarter ended December 31, 2023 amounted to $640.3 million, compared to $657.1 million in the same period last year.
Consolidated operating income for the fourth quarter ended December 31, 2023 amounted to $60.3 million compared to $60.2 million in the same period last year.
The absence of such employees resulted in lower profitability in the fourth quarter in certain areas of our operations.
Actual ratio of net financial indebtedness to net capitalization, as of December 31, 2023, was 1%.

Phoenix Holdings Publishes Financial Statements for Q4 and 2023

Retrieved on:

Wednesday, March 27, 2024

Phoenix Holdings Ltd., a leading Israel-based financial, insurance, and investment group (TLV:PHOE) (“Phoenix,” the “Group,” or the “Company”), today reported its results for the fourth quarter of 2023 and calendar year 2023.

Key Points:

Phoenix Holdings Ltd., a leading Israel-based financial, insurance, and investment group (TLV:PHOE) (“Phoenix,” the “Group,” or the “Company”), today reported its results for the fourth quarter of 2023 and calendar year 2023.
Phoenix is financially resilient with high levels of liquidity and a high Solvency II ratio for Phoenix Insurance, which reached 209% with transitional measures as of September 30, 2023.
Comprehensive income before tax in 2023 amounted to NIS 241 million, compared to NIS 235 million in 2022.
Comprehensive income before tax in 2023 amounted to NIS 307 million, compared to NIS 300 million in 2022.

Elbit Systems Announces Amendment to the Company's Proxy Statement

Retrieved on:

Monday, April 1, 2024

ISA, Employment, Attention, Elbit Systems, Mass meeting, Tel Aviv Stock Exchange, Meeting, Originality, Advanced Technology College, Proxy, Compensated emancipation, Postponed, Corporation

The Amended Compensation Policy and the Amended Employment Agreement are not otherwise modified.

Key Points:

The Amended Compensation Policy and the Amended Employment Agreement are not otherwise modified.
All shareholders voting at the Postponed Meeting (defined below) shall be voting on the agenda items as otherwise described in the Proxy Statement in the Original Report.
The record date for the original Meeting – March 4, 2024 – will remain unchanged, and will also be the record date for the Postponed Meeting.
Except as set forth above, the Proxy Statement has not been otherwise modified, and shall remain in force as filed with the Original Report.

Elbit Systems Announces the Filing of its Annual Report on Form 20-F for Fiscal Year 2023

Retrieved on:

Thursday, March 28, 2024

Annual report, Elbit Systems, Tel Aviv Stock Exchange

HAIFA, Israel, March 28, 2024 /PRNewswire/ -- Elbit Systems Ltd. (NASDAQ: ESLT) (TASE: ESLT) ("Elbit Systems" or the "Company") announced today that on March 28, 2024, the Company filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 (the "2023 Annual Report") with the U.S. Securities and Exchange Commission, the Israel Securities Authority and the Tel Aviv Stock Exchange.

Key Points:

HAIFA, Israel, March 28, 2024 /PRNewswire/ -- Elbit Systems Ltd. (NASDAQ: ESLT) (TASE: ESLT) ("Elbit Systems" or the "Company") announced today that on March 28, 2024, the Company filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 (the "2023 Annual Report") with the U.S. Securities and Exchange Commission, the Israel Securities Authority and the Tel Aviv Stock Exchange.
The 2023 Annual Report can be viewed or downloaded at the Company's website at: www.elbitsystems.com .
In addition, the Company will provide shareholders with a hard copy of the 2023 Annual Report upon request, free of charge.

Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification

Retrieved on:

Wednesday, March 20, 2024

Computational biology, Letter, Tel Aviv Stock Exchange, Calendar

The Nasdaq Stock Market Rules provide the Company with an additional period of 180 calendar days to regain compliance.

Key Points:

The Nasdaq Stock Market Rules provide the Company with an additional period of 180 calendar days to regain compliance.
According to the Letter, the Company has until September 16, 2024, to regain compliance with the minimum bid price requirement.
It is noted that Evogene's continued listing on Nasdaq remains a key priority for the Company.
The Letter from Nasdaq has no immediate effect on the Company's Nasdaq listing or the trading of its ordinary shares on Nasdaq, and during the aforementioned cure period, the Company's ordinary shares will continue to trade on the Nasdaq Capital Market under the symbol "EVGN".

Bravo Property Trust Hires Gabi Moshayev

Retrieved on:

Tuesday, February 27, 2024

Harel Group, Insurance, Tel Aviv Stock Exchange, Growth

NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Bravo Property Trust, an affiliate of Bravo Capital and a leading privately held bridge and construction lender with a national presence and expertise in real estate finance, is pleased to announce the addition of Gabi Moshayev as the Chairman of the Bravo Property Trust.

Key Points:

NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Bravo Property Trust, an affiliate of Bravo Capital and a leading privately held bridge and construction lender with a national presence and expertise in real estate finance, is pleased to announce the addition of Gabi Moshayev as the Chairman of the Bravo Property Trust.
Prior to joining Bravo Capital, Gabi Moshayev served as the CEO and worked on behalf of Harel Finance Alternative Ltd for fifteen years.
“We are confident that Gabi Moshayev will prove to be a valuable addition, contributing significantly to our continued growth, and ability to deliver exceptional and creative financing to our clients in the years ahead.” said Aaron Krawitz, CEO of Bravo Capital.
Mr. Moshayev stated, “I am excited to join a world-class financing organization, and to lead the next bridge fund.”
For more information about Bravo Property Trust, and Bravo Capital and its services, please visit https://www.bravocapital.com/ or contact (212-729-4962).

Arbe Announces Q4 and Full Year 2023 Financial Results

Retrieved on:

Thursday, March 7, 2024

Total, OEM, Radar, TEL, Original equipment manufacturer, ADAS, Tier 1, TAM, Entrepreneurship, Perception, Safety, RFQ, D&O, Insurance, Tel Aviv Stock Exchange

TEL AVIV, Israel, March 7, 2024 /PRNewswire/ -- Arbe Robotics Ltd. (NASDAQ: ARBE) ("Arbe"), a global leader in Perception Radar Solutions, today announced financial results for its fourth quarter and full year ended on December 31, 2023.

Key Points:

TEL AVIV, Israel, March 7, 2024 /PRNewswire/ -- Arbe Robotics Ltd. (NASDAQ: ARBE) ("Arbe"), a global leader in Perception Radar Solutions, today announced financial results for its fourth quarter and full year ended on December 31, 2023.
Gross margin in Q4 2023 was a negative 54.5%, compared to a negative gross margin of 45.6% in Q4 2022.
Operating expenses in Q4 2023 were $11.9 million, compared to $14.0 million in Q4 2022.
2023 Net loss included financial income of $3.4 million compared to $7.2 million of financial income in 2022.

The Tel-Aviv Stock Exchange Reports the Results of the Financial Statements for the Fourth Quarter and Full Year 2023

Retrieved on:

Wednesday, March 6, 2024

Revenues in the fourth quarter totaled NIS 101 million, compared to revenues of NIS 86 million in the corresponding quarter last year, an 18% increase.

Key Points:

Revenues in the fourth quarter totaled NIS 101 million, compared to revenues of NIS 86 million in the corresponding quarter last year, an 18% increase.
The adjusted profit in 2023 totaled NIS 89 million, compared to NIS 51 million in 2022, an increase of 74%.
The adjusted profit in the fourth quarter totaled NIS 23 million, compared to NIS 13 million in the corresponding quarter last year, an increase of 70%.
TEL AVIV, Israel, March 6, 2024 /PRNewswire/ -- The Tel-Aviv Stock Exchange Ltd. (TASE: TASE) today announced its financial results for the fourth quarter ended December 31, 2023 and for 2023.

IMC Announces Potential Reverse Merger with Kadimastem a leading Clinical cell therapy company

Retrieved on:

Wednesday, February 28, 2024

TORONTO and GLIL YAM, Israel, Feb. 28, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that it has entered into a non-binding term sheet dated February 13, 2024, as amended (the "Term Sheet"), and a Loan Agreement (as defined below) with Holding Company (as defined below), with Israel-based Kadimastem Ltd a clinical cell therapy public company traded on the Tel Aviv Stock Exchange under the symbol (TASE: KDST) ("Kadimastem"), whereby the parties will complete a business combination that will constitute a reverse merger into the Company by Kadimastem (the "Proposed Transaction").

Key Points:

We have been looking for a way to deliver maximum value for our shareholders in the current situation and believe that a reverse merger with Kadimastem will provide this," said Oren Shuster, CEO of IMC.
"With its focus on clinical stage cell therapy, and an FDA approval for a Phase IIa clinical trial, we believe that Kadimastem has tremendous potential."
The Proposed Transaction will be effected by way of a plan of arrangement involving a newly created wholly-owned subsidiary of IMC and Kadimastem (the "Arrangement").
Pursuant to the terms of the Term Sheet, a loan agreement dated February 28, 2024 (the "Loan Agreement") was entered between IMC Holdings Ltd. a wholly-owned subsidiary of IMC (the "Holding Company") and Kadimastem.